|
Designated Public Office Holders who participated in the communication:
|
Justine Frame,
Policy Advisor
Minister's Office,
Health Canada (HC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health
|
Health Canada's Legislative and Regulatory Modernization (LRM) as it relates to the review, approval, transparency and compliance activities of biopharmaceutical products. Health Canada's Regulatory Roadmap for Health Products and Food as it relates to proposed policy and regulatory changes related to the review, approval, transparency and compliance activities of biopharmacuetical products.
|
|
Federal-Provincial Relations,
Health
|
National Pharmaceutical Strategy as it relates to the federal government's involvement in federal/provincial access to medicines framework.
|
|
Intellectual Property,
Research and Development
|
Pharmaceutical pricing policy issues arising from the jurisdiction of the Patended Medicines Prices Review Board (PMPRB) and R&D reporting.
|
|
Health,
Industry
|
Smart Regulations as it relates to the biopharmaceutical industry.
|
|
| |
|
Communication Report amended on:
|
2026-04-20 previous entry:
12241-677664
|
|
Reason for amendment:
|
Discrepancy in the DPOH position title was corrected: Originally was Special Assistant Policy, ammeded to say Policy Advisor.
|
| |
|
Responsible Officer who filed this communication report:
|
David D. Jones
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
